Federal Marijuana Policy
The House Energy and Commerce Subcommittee on Health held a hearing to examine federal marijuana policy, including the implications of chang… read more
The House Energy and Commerce Subcommittee on Health held a hearing to examine federal marijuana policy, including the implications of changing its drug schedule listing and the potential of cannabis research. Witnesses from the National Institute on Drug Abuse, the Food and Drug Administration (FDA) and the Drug Enforcement Administration (DEA) testified on current marijuana policy, the health effects of cannabis, and what steps Congress can take to allow for more research of cannabis compounds and products. close
Points of Interest
For quick viewing, C-SPAN provides Points of Interest markers for some events.
Click the play button and tap the screen to see the at the bottom of the player. Tap the to see a complete list of all Points of Interest - click on any moment in the list and the video will play.
Points of Interest
For quick viewing, C-SPAN provides Points of Interest markers for some events.
Click the play button and move your cursor over the video to see the . Click on the marker to see the description and watch.
You can also click the in the lower left of the video player to see a complete list of all Points of Interest from this program - click on any moment in the list and the video will play.
People in this video
-
Doug Throckmorton M.D. Deputy Director U.S. Food and Drug Administration->Center for Drug Evaluation and Research
Hosting Organization
Related Video
-
Internet and Consumer Protection
Google and Reddit officials testified before two House Energy and Commerce subcommittees about internet privacy and cons…
-
Open Internet Rules and Broadband Access
Two former Federal Communications Commission chairs, Tom Wheeler (D) and Michael Powell (R), testified at a House Energy…
-
Hearing on 5G Wireless Technology
Telecommunications industry officials testified on efforts to secure 5G wireless networks at a virtual House Energy and …
-
House Hearing on the Regulation of Fentanyl-Related Substances
The House Energy and Commerce Subcommittee on Health held a hearing with Biden administration officials to examine effor…